LYTIR

Insider · SEC Form 4 · President, R&D

Bergstrom Donald A

In the 12 months to Nov 8, 2026, on the open market: sold $2.0M of RLAY. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $2.0M in total.Jun: Insider sales $1.6MJul: Insider sales $204KSep: Insider sales $162KOct: Insider sales $42KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $2.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. RLAYSold: Relay Therapeutics, Inc. Oct 28, 2026 2,252 shares filed Oct 30, 2026 396,878 shares held directly after, as filed filing $42K
  2. RLAYSold: Relay Therapeutics, Inc. Sep 8, 2026 8,530 shares filed Sep 9, 2026 399,130 shares held directly after, as filed 10b5-1 plan filing $162K
  3. RLAYSold: Relay Therapeutics, Inc. Jul 28, 2026 2,237 shares filed Jul 30, 2026 407,660 shares held directly after, as filed filing $42K
  4. RLAYSold: Relay Therapeutics, Inc. Jul 6, 2026 8,660 shares filed Jul 8, 2026 409,897 shares held directly after, as filed 10b5-1 plan filing $162K
  5. RLAYSold: Relay Therapeutics, Inc. Jun 22, 2026 93,456 shares filed Jun 24, 2026 418,557 shares held directly after, as filed 10b5-1 plan filing $1.6M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • RLAY: option exercise or conversion (code M), 1 entry, Jun 22, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.